Professional Documents
Culture Documents
com/en-gb/innovation/
Innovation
The next era of HIV Innovation
We think about HIV everyday so people like Warren don't have to
0:31
1 of 12 4/13/23, 21:02
Innovation | GSK https://www.gsk.com/en-gb/innovation/
Scroll to explore
GSK logo linking to the homepage
2 of 12 4/13/23, 21:02
Innovation | GSK https://www.gsk.com/en-gb/innovation/
We’re combining the power of genetic and genomic insights into what causes
disease, with the speed and scale of artificial intelligence and machine
learning (AI/ML) to make better predictions about who a treatment might
work for, and why.
We believe this powerful combination of data and technology holds the key to
fundamentally transforming medical discovery for the better, improving R&D
success rates and shaping how even the most challenging diseases, like
neurological conditions and cancer, can be both prevented and treated.
£5.5bn 15k
3 of 12 4/13/23, 21:02
Innovation | GSK https://www.gsk.com/en-gb/innovation/
01 / 06
FINANCIAL TIMES
The latest in vaccine science and technology offers the potential of a healthier l
4 of 12 4/13/23, 21:02
Innovation | GSK https://www.gsk.com/en-gb/innovation/
A SSE TS
69
potential vaccines and specialty
medicines in 2022
FOCUS
2/3rds
of our pipeline comes from
infectious diseases and HIV
Our pipeline
As a global biopharma leader, we invest heavily in our industry-
leading pipeline of potential vaccines and specialty medicines
that help us to get ahead of disease together.
Our pipeline
5 of 12 4/13/23, 21:02
Innovation | GSK https://www.gsk.com/en-gb/innovation/
18
assets in phase III/registration in
2022
APPROVAL S
>20
new approvals since 2017
Therapeutic areas
The four areas of human health we focus on to get ahead of disease are:
infectious diseases, HIV, immunology/respiratory, and oncology. We remain
open to opportunities outside these core areas where the science aligns with
our strategic approach.
6 of 12 4/13/23, 21:02
Innovation | GSK https://www.gsk.com/en-gb/innovation/
HIV
Infectious Immuno
diseases respirato
� �
7 of 12 4/13/23, 21:02
Innovation | GSK https://www.gsk.com/en-gb/innovation/
Hear from industry experts, explore the latest breakthroughs and network with
GSK logo linking to the homepage us.
American Society
JP Morgan of Hematology Europea
Healthcare 2022 for Med
Conference 2023 Exploring the potential of our
pipeline and therapies to
Oncolog
GSK was at the 41st J.P. Morgan transform blood cancer Showcasing ou
Health care conference in San treatments. maximise the p
Francisco. oncology portf
patient surviva
Conferences
9 of 12 4/13/23, 21:02
Innovation | GSK https://www.gsk.com/en-gb/innovation/
10 of 12 4/13/23, 21:02
Innovation | GSK https://www.gsk.com/en-gb/innovation/
Learn how our people are using their talents and passions to focus on
Working together, Thriving together and Innovating together.
11 of 12 4/13/23, 21:02
Innovation | GSK https://www.gsk.com/en-gb/innovation/
GSK logo
Continue to linking to the homepage
Products
This is our global website, intended for visitors seeking information on GSK's worldwide business. Our market sites can be
reached by visiting our location selector.
© 2001-2023 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.
12 of 12 4/13/23, 21:02